CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment.
Saved in:
| Title: | CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment. |
|---|---|
| Authors: | Takahashi K; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.; Institute of Industrial Science, The University of Tokyo, Tokyo, Japan., Kobayashi M; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Katsumata H; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Tokizaki S; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.; Department of Oral and Maxillofacial Surgical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Anzai T; Department of Biostatistics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan., Ikeda Y; Institute of Industrial Science, The University of Tokyo, Tokyo, Japan., Alcaide DM; Institute of Industrial Science, The University of Tokyo, Tokyo, Japan., Maeda K; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Ishihara M; Scientific Affairs Section, Life Science Sales Department, Life Science Business Division, Medical Business Group, Sony Corporation, Kanagawa, Japan., Tahara K; Section 1, Product Design Department 2, Medical Product Design Division, Medical Business Group, Sony Corporation, Kanagawa, Japan., Kubota Y; Department of Anatomy, Keio University School of Medicine, Tokyo, Japan., Itoh F; Laboratory of Stem Cells Regulations, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Park J; School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, South Korea., Takahashi K; Department of Biostatistics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan., Matsunaga YT; Institute of Industrial Science, The University of Tokyo, Tokyo, Japan., Yoshimatsu Y; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Division of Pharmacology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan., Podyma-Inoue KA; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Watabe T; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. |
| Source: | Cancer science [Cancer Sci] 2024 Feb; Vol. 115 (2), pp. 490-506. Date of Electronic Publication: 2023 Dec 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1349-7006 |
|---|---|
| DOI: | 10.1111/cas.16045 |
